The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges
- Michaela Aubele
- , Manfred Schmitt
- , Rudolf Napieralski
- , Stefan Paepke
- , Johannes Ettl
- , Magdalena Absmaier
- , Viktor Magdolen
- , John Martens
- , John A. Foekens
- , Olaf G. Wilhelm
- , Marion Kiechle
- Therawis Diagnostics GmbH
- Technical University of Munich
- Erasmus MC Cancer Institute
Research output: Contribution to journal › Review article › peer-review
29
Scopus
citations